Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) Short Interest Down 62.4% in June

Therapeutic Solutions International, Inc. (OTCMKTS:TSOI) was the recipient of a significant decrease in short interest during the month of June. As of June 30th, there was short interest totalling 56,000 shares, a decrease of 62.4% from the June 15th total of 149,100 shares. Based on an average daily trading volume, of 8,400,900 shares, the days-to-cover ratio is presently 0.0 days.

Therapeutic Solutions International Stock Performance

Shares of OTCMKTS TSOI remained flat at $0.00 during mid-day trading on Thursday. 6,607,153 shares of the company were exchanged, compared to its average volume of 21,319,119. Therapeutic Solutions International has a 1 year low of $0.00 and a 1 year high of $0.00.

Therapeutic Solutions International Company Profile

Therapeutic Solutions International, Inc focuses on immune modulation for the treatment of various specific diseases. The company develops a range of immune-modulatory agents to cancers, schizophrenia, suicidal ideation, traumatic brain injury, and lung pathologies, as well as for daily health. Its flagship products consist of QuadraMune, a patented synergistic blend of pterostilbene, sulforaphane, epigallocatechingallate, and thymoquionone to increase natural killer cell activity and healthy cytokine production.